D. Krause

发表

Improved radiological outcome of rheumatoid arthritis: the importance of early treatment with methotrexate in the era of biological drugs

R. Rau, S. Wassenberg, C. Fiehn, 2013, Clinical Rheumatology.

IMPROVED RADIOLOGICAL OUTCOME OF RHEUMATOID ARTHRITIS: EARLY TREATMENT WITH METHOTREXATE MIGHT BE A KEY PROGNOSTIC FACTOR

R. Rau, S. Wassenberg, C. Fiehn, 2012 .

Effects of Three Different Methods Defining Onset of Peripheral Artery Disease on the Assessments of Incidence and Important Predictors – Results from the German Epidemiological Trial on Ankle Brachial Index (getABI)

H. Trampisch, H. Rudolf, R. Klaassen-Mielke, 2021, Vascular health and risk management.

Gamma-glutamyl transferase as a risk factor for mortality and cardiovascular events in older adults - results from a prospective cohort study in a primary care setting (getABI).

C. Diehm, H. Trampisch, H. Rudolf, 2019, VASA. Zeitschrift fur Gefasskrankheiten.

Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data

B. Wieseler, M. F. Kerekes, Petra Kohlepp, 2020, BMJ.

Efficiency of treatment with non-steroidal anti-inflammatory drugs according to current recommendations in patients with radiographic and non-radiographic axial spondyloarthritis

S. Peters, J. Braun, U. Kiltz, 2017, Rheumatology.

The Structured Delegation of Medical Care Services for Patients With Inflammatory Rheumatic Diseases-Findings of a Randomized Controlled Trial (the StärkeR Project).

J. Reese, J. Braun, H. Trampisch, 2022, Deutsches Arzteblatt international.

The risk of peripheral artery disease in older adults - seven-year results of the getABI study.

C. Diehm, H. Trampisch, M. Trampisch, 2016, VASA. Zeitschrift fur Gefasskrankheiten.

[Evaluation of a basic educational program for patients with rheumatoid arthritis].

J. Braun, A. Reusch, H. Lakomek, 2020, Zeitschrift fur Rheumatologie.

Dose tapering of biologic agents in patients with rheumatoid arthritis—results from a cohort study in Germany

J. Braun, X. Baraliakos, H. Rudolf, 2020, Clinical Rheumatology.

Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response

H. Lorenz, C. Fiehn, N. Blank, 2016, Journal of Rheumatology.

Glucocorticoid treatment in early rheumatoid arthritis.

R. Rau, J. Braun, D. Krause, 2011, Clinical and experimental rheumatology.

The Efficacy of Short‐Term Bridging Strategies With High‐ and Low‐Dose Prednisolone on Radiographic and Clinical Outcomes in Active Early Rheumatoid Arthritis: A Double‐Blind, Randomized, Placebo‐Controlled Trial

C. Schade-Brittinger, R. Rau, S. Wassenberg, 2022, Arthritis & rheumatology.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Chenot, A. Stallmach, J. Braun, 2014, Zeitschrift für Rheumatologie (Print).

A systematic comparison of different composite measures (DAS 28, CDAI, SDAI, and Boolean approach) for determining treatment effects on low disease activity and remission in rheumatoid arthritis

B. Wieseler, N. Mcgauran, B. Richter, 2022, BMC rheumatology.

Do patients with non‐radiographic axial spondylarthritis differ from patients with ankylosing spondylitis?

J. Braun, U. Kiltz, X. Baraliakos, 2012, Arthritis care & research.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 6 Diagnostics].

J. Braun, J. Sieper, U. Kiltz, 2014, Zeitschrift fur Rheumatologie.

Chronic but not inflammatory changes at the Achilles’ tendon differentiate patients with peripheral spondyloarthritis from other diagnoses – Results from a prospective clinical trial

J. Braun, U. Kiltz, X. Baraliakos, 2017, RMD Open.

Response to methotrexate treatment is associated with reduced mortality in patients with severe rheumatoid arthritis.

R. Rau, D. Krause, G. Herborn, 2000, Arthritis and rheumatism.

Interactions between C-reactive protein and traditional risk factors in predicting mortality of older adults.

C. Diehm, H. Trampisch, U. Thiem, 2017, VASA. Zeitschrift fur Gefasskrankheiten.

[Concomitant manifestation of ochronosis and chronic polyarthritis in a patient].

R. Rau, S. Simianer, D. Krause, 1998, Zeitschrift fur Rheumatologie.

The positive influence of methotrexate on the mortality of patients with rheumatoid arthritis is partly independent of its effect on disease activity: results of a re-evaluation 18 years after baseline.

R. Rau, J. Braun, D. Krause, 2014, Clinical and experimental rheumatology.

Nurse-led care versus physician-led care in the management of rheumatoid arthritis and psoriatic arthritis (StaerkeR): study protocol for a multi-center randomized controlled trial

J. Reese, J. Braun, H. Trampisch, 2019, Trials.

Reduction of potentially inappropriate medication in the elderly—results of a cluster-randomized, controlled trial in German primary care practices (RIME)

W. Greiner, S. Wilm, H. Trampisch, 2021, Deutsches Ärzteblatt international.

The degree of spinal inflammation is similar in patients with axial spondyloarthritis who report high or low levels of disease activity: a cohort study

J. Braun, U. Kiltz, M. Bollow, 2012, Annals of the rheumatic diseases.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 5 Initial diagnosis/referral strategy].

A. Heiligenhaus, J. Chenot, B. Swoboda, 2014, Zeitschrift fur Rheumatologie.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 7 Disease activity and prognosis of spondyloarthritis].

B. Swoboda, J. Braun, J. Sieper, 2014, Zeitschrift fur Rheumatologie.

Socioeconomic factors and the onset of peripheral artery disease in older adults.

H. Trampisch, N. Timmesfeld, Julia Kreutzer, 2021, VASA. Zeitschrift fur Gefasskrankheiten.

[Glucocorticoids in rheumatic diseases - what is the optimal dose?].

D. Krause, 2012, Deutsche medizinische Wochenschrift.

[Long version on the S3 guidelines for axial spondyloarthritis including Bechterew's disease and early forms, Update 2019 : Evidence-based guidelines of the German Society for Rheumatology (DGRh) and participating medical scientific specialist societies and other organizations].

A. Heiligenhaus, M. Dreimann, J. Chenot, 2019, Zeitschrift fur Rheumatologie.

Response to methotrexate predicts long-term patient-related outcomes in rheumatoid arthritis

R. Rau, J. Braun, D. Krause, 2016, Clinical Rheumatology.

[Memorandum of the German Society for Rheumatology on the quality of treatment in rheumatology - Update 2016].

U. Müller-Ladner, J. Braun, E. Gromnica-ihle, 2017, Zeitschrift fur Rheumatologie.

Diagnostic value of a 3-day course of prednisolone in patients with possible rheumatoid arthritis – the TryCort study

J. Braun, U. Kiltz, X. Baraliakos, 2017, Arthritis Research & Therapy.

Potentially inappropriate medication including drug-drug interaction and the risk of frequent falling, hospital admission, and death in older adults - results of a large cohort study (getABI)

H. Trampisch, R. Klaassen-Mielke, D. Krause, 2023, Frontiers in Pharmacology.

Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis

J. Braun, U. Kiltz, X. Baraliakos, 2018, Rheumatology.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 8 Therapy, 8.1 Treatment concept, 8.2 Therapy targets and strategy].

A. Heiligenhaus, J. Chenot, B. Swoboda, 2014, Zeitschrift fur Rheumatologie.

Quantification of Bone Marrow Edema by Magnetic Resonance Imaging Only Marginally Reflects Clinical Neck Pain Evaluation in Rheumatoid Arthritis and Ankylosing Spondylitis

J. Braun, U. Kiltz, X. Baraliakos, 2016, The Journal of Rheumatology.

The efficacy of a nurse-led interventional program to improve the health of patients with axial spondyloarthritis.

J. Braun, U. Kiltz, D. Krause, 2020, Rheumatology.

Does residential exposure to air pollutants influence mortality and cardiovascular morbidity of older people from primary care?

H. Trampisch, M. Trampisch, R. Klaassen-Mielke, 2023, BMC Public Health.

Radiologic damage at baseline predicts patient-related outcomes 18 years after the initiation of methotrexate therapy in patients with severe rheumatoid arthritis.

R. Rau, J. Braun, D. Krause, 2015, Clinical and Experimental Rheumatology.

[Development of quality standards for patients with axial spondyloarthritis for use in Germany].

U. Syrbe, H. Schulze-Koops, J. Braun, 2021, Zeitschrift fur Rheumatologie.

[German Society for Rheumatology S3 guidelines on axial spondyloarthritis including Bechterew's disease and early forms: 1 Introduction/preliminary comments].

A. Heiligenhaus, J. Chenot, B. Swoboda, 2014, Zeitschrift fur Rheumatologie.

Comparison of the efficacy and safety of two starting dosages of prednisolone in early active rheumatoid arthritis (CORRA): study protocol for a randomized controlled trial

J. Braun, X. Baraliakos, H. Trampisch, 2014, Trials.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

B. Swoboda, A. Stallmach, A. Stallmach, 2014, Zeitschrift für Rheumatologie.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Chenot, A. Stallmach, A. Stallmach, 2014, Zeitschrift für Rheumatologie.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

B. Swoboda, A. Stallmach, A. Stallmach, 2014, Zeitschrift für Rheumatologie.

Rituximab in the Treatment of Jo1 Antibody–associated Antisynthetase Syndrome: Anti-Ro52 Positivity as a Marker for Severity and Treatment Response

H. Lorenz, C. Fiehn, N. Blank, 2016, The Journal of Rheumatology.

DGRh-S3-Leitlinie Axiale Spondyloarthritis inklusive Morbus Bechterew und Frühformen

J. Braun, J. Sieper, D. Krause, 2014, Zeitschrift für Rheumatologie.